150 related articles for article (PubMed ID: 33444574)
21. Immunoglobulin G directed against toxins A and B of Clostridium difficile in the general population and patients with antibiotic-associated diarrhea.
Bacon AE; Fekety R
Diagn Microbiol Infect Dis; 1994 Apr; 18(4):205-9. PubMed ID: 7924215
[TBL] [Abstract][Full Text] [Related]
22. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S
Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701
[TBL] [Abstract][Full Text] [Related]
23. Treatment with monoclonal antibodies against Clostridium difficile toxins.
Lowy I; Molrine DC; Leav BA; Blair BM; Baxter R; Gerding DN; Nichol G; Thomas WD; Leney M; Sloan S; Hay CA; Ambrosino DM
N Engl J Med; 2010 Jan; 362(3):197-205. PubMed ID: 20089970
[TBL] [Abstract][Full Text] [Related]
24. Clostridioides difficile Infection Induces an Inferior IgG Response to That Induced by Immunization and Is Associated with a Lack of T Follicular Helper Cell and Memory B Cell Expansion.
Amadou Amani S; Shadid T; Ballard JD; Lang ML
Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31871095
[TBL] [Abstract][Full Text] [Related]
25. Association between IgG2 and IgG3 subclass responses to toxin A and recurrent Clostridium difficile-associated disease.
Katchar K; Taylor CP; Tummala S; Chen X; Sheikh J; Kelly CP
Clin Gastroenterol Hepatol; 2007 Jun; 5(6):707-13. PubMed ID: 17544998
[TBL] [Abstract][Full Text] [Related]
26. Is it unethical to conduct placebo-controlled trials of faecal microbiota transplantation for recurrent Clostridioides difficile infection?
Kelly CR; Kahn SA
Lancet Gastroenterol Hepatol; 2020 May; 5(5):432-433. PubMed ID: 32277897
[No Abstract] [Full Text] [Related]
27. Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A.
Aboudola S; Kotloff KL; Kyne L; Warny M; Kelly EC; Sougioultzis S; Giannasca PJ; Monath TP; Kelly CP
Infect Immun; 2003 Mar; 71(3):1608-10. PubMed ID: 12595488
[TBL] [Abstract][Full Text] [Related]
28. Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI).
Leav BA; Blair B; Leney M; Knauber M; Reilly C; Lowy I; Gerding DN; Kelly CP; Katchar K; Baxter R; Ambrosino D; Molrine D
Vaccine; 2010 Jan; 28(4):965-9. PubMed ID: 19941990
[TBL] [Abstract][Full Text] [Related]
29. Does Fecal Microbiota Transplant Have a Role in Treating Recurrent
Vedala K; Sobash P; Shah P; Kamoga GR
Front Public Health; 2021; 9():670941. PubMed ID: 34178927
[No Abstract] [Full Text] [Related]
30. Is it reasonable to perform Fecal Microbiota Transplantation for recurrent Clostridium difficile Infection in patients with liver cirrhosis?
Olmedo M; Reigadas E; Valerio M; Vázquez-Cuesta S; Pajares JA; Matilla A; Muñoz P; Bouza E
Rev Esp Quimioter; 2019 Apr; 32(2):205-207. PubMed ID: 30847461
[No Abstract] [Full Text] [Related]
31. Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease.
Gravito-Soares M; Gravito-Soares E; Portela F; Ferreira M; Sofia C
Rev Esp Enferm Dig; 2017 Jun; 109(6):473-476. PubMed ID: 28506071
[TBL] [Abstract][Full Text] [Related]
32. Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection.
Kink JA; Williams JA
Infect Immun; 1998 May; 66(5):2018-25. PubMed ID: 9573084
[TBL] [Abstract][Full Text] [Related]
33. Fecal microbiota transplantation and emerging treatments for Clostridium difficile infection.
Gens KD; Elshaboury RH; Holt JS
J Pharm Pract; 2013 Oct; 26(5):498-505. PubMed ID: 23966282
[TBL] [Abstract][Full Text] [Related]
34. Fecal microbiota transplant to treat recurrent Clostridium difficile infections.
Boyle ML; Ruth-Sahd LA; Zhou Z
Crit Care Nurse; 2015 Apr; 35(2):51-64; quiz 65. PubMed ID: 25834008
[TBL] [Abstract][Full Text] [Related]
35. Identification of toxemia in patients with Clostridium difficile infection.
Yu H; Chen K; Wu J; Yang Z; Shi L; Barlow LL; Aronoff DM; Garey KW; Savidge TC; von Rosenvinge EC; Kelly CP; Feng H
PLoS One; 2015; 10(4):e0124235. PubMed ID: 25885671
[TBL] [Abstract][Full Text] [Related]
36. Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial.
Hota SS; Sales V; Tomlinson G; Salpeter MJ; McGeer A; Coburn B; Guttman DS; Low DE; Poutanen SM
Clin Infect Dis; 2017 Feb; 64(3):265-271. PubMed ID: 28011612
[TBL] [Abstract][Full Text] [Related]
37. The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins.
Erickson SL; Alston L; Nieves K; Chang TKH; Mani S; Flannigan KL; Hirota SA
FASEB J; 2020 Feb; 34(2):2198-2212. PubMed ID: 31907988
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the premier toxin A and B assay and the TOX A/B II assay for diagnosis of Clostridium difficile infection.
Novak-Weekley SM; Hollingsworth MH
Clin Vaccine Immunol; 2008 Mar; 15(3):575-8. PubMed ID: 18175802
[TBL] [Abstract][Full Text] [Related]
39. Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration.
Negm OH; MacKenzie B; Hamed MR; Ahmad OAJ; Shone CC; Humphreys DP; Ravi Acharya K; Loscher CE; Marszalowska I; Lynch M; Wilcox MH; Monaghan TM
Clin Exp Immunol; 2017 Jun; 188(3):437-443. PubMed ID: 28213939
[TBL] [Abstract][Full Text] [Related]
40. Faecal microbiota transplantation for
Terveer EM; Vendrik KE; Ooijevaar RE; Lingen EV; Boeije-Koppenol E; Nood EV; Goorhuis A; Bauer MP; van Beurden YH; Dijkgraaf MG; Mulder CJ; Vandenbroucke-Grauls CM; Seegers JF; van Prehn J; Verspaget HW; Kuijper EJ; Keller JJ
United European Gastroenterol J; 2020 Dec; 8(10):1236-1247. PubMed ID: 32990503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
